universal influenza A and B vaccine (JVRS-100) (Juvaris)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameuniversal influenza A and B vaccine (JVRS-100) (Juvaris)

Drug Alias NameM2e-peptide antigen-containing influenza vaccine (JVRS-100) (Juvaris)

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJuvaris Biotherapeutics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJuvaris Biotherapeutics

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A